Outer Web | Explore

/explore

Click through on any links that interest you or select the planets on the right to continue exploring the Outer Web.

You are here		bennettftomlin.com Tether's Executives are Deeply Conflicted-Bennett's Blog
\|	\|	investmenttimesdaily.com Payments and Credit Association Names Scott Whalen Executive of the Year - Investment Times Daily	4.5 parsecs away Travel
\|	\|	Press Release For Immediate Release Contact:Jane Smith, Communications DirectorPayments and Credit Association Payments and Credit Association Names Scott Whalen Executive of the Year New York, NY, January 25, 2024 - The Payments and Credit Association announced today that it has named Scott Whalen, Managing Director and Head of Credit Management at Silicon Valley Bank, as...	4.5 parsecs away Travel
\|	\|	johngannonblog.com VC Jobs Archive - VC Jobs & Newsletter	4.1 parsecs away Travel
\|	\|	Senior Associate/Manager of Media, E-Commerce & Technology VC Job at Cantor Ventures in NYC (posted 6/30/15) Associate VC Job at OpenView Venture Partners in Boston (posted 6/30/15) Analyst VC Job at Saints Capital in San Francisco (posted 6/26/15) Associate VC Job at Lewis & Clark Ventures in St. Louis (posted 6/26/15) Portfolio Manager VC Job...	4.1 parsecs away Travel
\|	\|	biosimilarsrr.com Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved \|	4.7 parsecs away Travel
\|	\|	It's been a busy couple of weeks, and we're taking this time to catch up on some specific biosimilar product news. Samsung Bioepis and Teva Launches Their Eculizumab Biosimilar The biosimilar maker Samsung Bioepis and its marketing partner Teva Pharmaceuticals announced on April 7 that it had launched Epysqli in the United States. This is ... Continue reading Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved	4.7 parsecs away Travel
\|	\|	www.sethlevine.com The Markets Are Great . . . but Venture Outcomes Haven't Changed Much-SETH LEVINE's VC ADVENTURE	25.6 parsecs away Travel
\|		A few years back I blogged about the hard data behind venture outcomes and the challenge of creating a venture portfolio that produces strong returns. That blog post - which turned into one of my most read posts ever - grew out of a study done by Correlation Ventures showing the distribution of outcomes across over 21,000 financings during the years 2004-2013 as well as some of my own observations. The Correlation study produced a lot of interesting data and showed that the typical "1/3, 1/3, 1/3" model that many VCs talk about was significantly more optimistic than the reality of typical venture returns. The vast majority (almost 2/3rds) of venture financings fail to return capital. And only about 4% produce a return of greater than 10x. Pretty humbling. He...	25.6 parsecs away Travel